Comparative effectiveness research: what impact does it have on health care decision-making?

It will require multiple weapons to successfully combat chronic diseases and the damage they do to individuals and to our health care system. Comparative effectiveness research – the science of comparing and determining which treatments and therapies have the greatest success in achieving positive patient outcomes – can be an important part of that arsenal. It’s important to understand exactly how key stakeholders in the health care system may value and utilize this research as it becomes available.

That’s the topic of a webinar being hosted by the National Pharmaceutical Council on Thursday, March 26. It’s taking place from 12:30 p.m. to 1:30 p.m., ET, and information on how to register for the event can be found here.

Much of the webinar will be devoted to the findings of the Council’s fifth annual survey of the organizations – payers, academia, employers, health care associations – that are most likely to use comparative effectiveness research. The survey provides a snapshot on how these organizations value this research and the impact they believe it will have on health care decision-making. Among those speaking at the webinar will be Joe Selby, M.D., the executive director of the Patient-Centered Outcomes Research Institute (PCORI), the organization that has been issuing grants for comparative effectiveness studies.

This webinar will help us better understand an important tool that can help in our ongoing fight against cancer, heart disease, diabetes and other chronic illnesses that are costing our society both lives and resources.